• Home
  • Study Details
Coming Soon

PRevention Of Frailty with Fisetin (PROFFi) in Breast Cancer Survivors

The purpose of this research study is to examine the effectiveness of the nutritional supplement, fisetin, in improving physical function in women treated for breast cancer.

Age & Gender

  • 18 years ~ 70 years
  • Female, Gender Inclusive

Contact the Team

Location

Thank you for your interest, but this study will start enrolling soon.

United States (Nationwide)

Additional Study Information

Principal Investigator

Hyman Muss
LCCC - Clinical Trials

Study Type

Clinical or Medical
Interventional

Study Topics

Cancer (Breast)

IRB Number

23-2199

ClinicalTrials.gov

NCT06113016

Research for Me logo

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.
logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research